Taul-Madsen Laurits, Hvid Lars G, Riis Hjalte, Broløs Magnus K, Lundbye-Jensen Jesper, Dalgas Ulrik
Exercise Biology, Department of Public Health, Aarhus University, Aarhus, Denmark.
Exercise Biology, Department of Public Health, Aarhus University, Aarhus, Denmark; The Danish MS Hospitals, Ry and Haslev, Haslev, Denmark.
Mult Scler. 2025 Feb;31(2):174-183. doi: 10.1177/13524585241305496. Epub 2024 Dec 30.
Exercise is a safe and effective way to improve physical function in people with multiple sclerosis (PWMS).
This study aimed to perform a head-to-head study of the effects of aerobic and resistance training on physical capacity and physical function.
A multicentre randomized controlled trial with 150 participants was conducted. Participants were randomized into 12 weeks of either aerobic training (AT; = 62), resistance training (RT; = 57), or usual care (UC; = 31). The primary outcome was physical function (measured as a composite score of the 6-minute walk test and five-time sit-to-stand). Secondary outcomes were aerobic capacity (VOpeak), maximal muscle strength (MVC), and self-reported walking ability.
Participants had a mean age of 45.5 (8.8), an expanded disability status scale (EDSS) of 2.8 (1.5), and 75% were female. Physical function did not increase in AT versus UC 0.08 [-0.16; 0.33] (mean (95% CI)) nor in RT versus UC 0.09 [-0.15; 0.34].VOpeak increased in AT versus UC by 4.1 [2.0; 6.3] mL O/min/kg and in AT versus RT by 2.7 [1.1; 4.3], but not in RT versus UC 1.4 [-0.6; 3.5]. MVC increased in RT versus UC by 0.25 [0.01; 0.48] Nm/kg, but not in RT versus AT 0.17 [-0.02; 0.36] or AT versus UC 0.08 [-0.16; 0.31]).
AT and RT elicited improvements in physical capacity in PWMS. However, these improvements only moderately translated into improvements in physical function.Clinicaltrials.gov (NCT04913012)https://clinicaltrials.gov/study/NCT04913012.
运动是改善多发性硬化症患者(PWMS)身体功能的一种安全有效的方法。
本研究旨在对有氧训练和抗阻训练对身体能力和身体功能的影响进行直接比较研究。
进行了一项有150名参与者的多中心随机对照试验。参与者被随机分为接受12周的有氧训练(AT;n = 62)、抗阻训练(RT;n = 57)或常规护理(UC;n = 31)。主要结局是身体功能(以6分钟步行试验和五次坐立试验的综合评分衡量)。次要结局是有氧能力(VO₂峰值)、最大肌肉力量(MVC)和自我报告的步行能力。
参与者的平均年龄为45.5(8.8)岁,扩展残疾状态量表(EDSS)为2.8(1.5),75%为女性。与UC相比,AT组的身体功能没有增加0.08 [-0.16;0.33](均值(95%CI)),与UC相比,RT组也没有增加0.09 [-0.15;0.34]。与UC相比,AT组的VO₂峰值增加了4.1 [2.0;6.3] mL O₂/min/kg,与RT相比增加了2.7 [1.1;4.3],但与UC相比,RT组没有增加1.4 [-0.6;3.5]。与UC相比,RT组的MVC增加了0.25 [0.01;0.48] Nm/kg,但与AT相比没有增加0.17 [-0.02;0.36],与UC相比,AT组也没有增加0.08 [-0.16;0.31])。
AT和RT可改善PWMS的身体能力。然而,这些改善仅适度转化为身体功能的改善。Clinicaltrials.gov(NCT04913012)https://clinicaltrials.gov/study/NCT04913012。